Novozymes A/S
General ticker "NVZMF" information:
- Sector: Materials
- Industry: Chemicals - Specialty
- Capitalization: $17.4B (TTM average)
Novozymes A/S does not follow the US Stock Market performance with the rate: -4.3%.
Estimated limits based on current volatility of 2.2%: low 53.14$, high 55.50$
Factors to consider:
- Company pays dividends (irregularly): last record date 2025-08-22, amount 0.35$ (Y0.67%)
- Earnings for 12 months up through Q4 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [34.08$, 58.75$]
- 2025-12-31 to 2026-12-31 estimated range: [32.69$, 56.29$]
Financial Metrics affecting the NVZMF estimates:
- Negative: with PPE of 70.8 at the end of fiscal year the price was high
- Positive: 7.67 < Operating profit margin, % of 13.07
- Positive: Return on assets ratio (scaled to [-100,100]) of 13.05 > 6.11
- Negative: Operating cash flow per share per price, % of 0.55 <= 6.64
- Positive: Investing cash flow per share per price, % of -0.11 > -0.63
- Positive: Shareholder equity ratio, % of 73.55 > 64.29
- Positive: 0.23 < Industry earnings per price (median), % of 2.34
Short-term NVZMF quotes
Long-term NVZMF plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 |
|---|---|---|
| Operating Revenue | DKK17,905.94MM | DKK28,590.09MM |
| Operating Expenses | DKK13,928.50MM | DKK24,853.65MM |
| Operating Income | DKK3,977.44MM | DKK3,736.44MM |
| Non-Operating Income | DKK-66.34MM | DKK-625.72MM |
| Interest Expense | DKK23.24MM | DKK76.40MM |
| R&D Expense | DKK2,017.79MM | DKK3,081.63MM |
| Income(Loss) | DKK3,911.10MM | DKK3,110.72MM |
| Taxes | DKK870.62MM | DKK830.07MM |
| Profit(Loss)* | DKK3,025.57MM | DKK305.80MM |
| Stockholders Equity | DKK13,978.00MM | DKK11,176.00MM |
| Inventory | DKK3,627.00MM | DKK720.60MM |
| Assets | DKK28,391.00MM | DKK15,195.60MM |
| Operating Cash Flow | DKK4,152.00MM | DKK1,019.90MM |
| Capital expenditure | DKK2,056.00MM | DKK359.80MM |
| Investing Cash Flow | DKK-2,133.00MM | DKK-199.70MM |
| Financing Cash Flow | DKK-1,889.00MM | DKK-703.20MM |
| Earnings Per Share** | DKK10.89 | DKK0.67 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.